BioScrip (BIOS) Misses Q4 EPS by 70c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Join SI Premium – FREE
BioScrip (NASDAQ: BIOS) reported Q4 EPS of ($0.69), $0.70 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $253.7 million versus the consensus estimate of $259.62 million.
For earnings history and earnings-related data on BioScrip (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- SpaceX shares continue higher following Anthropic's $120.5bn AI deal
- HBT Financial (HBT) PT Raised to $43 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
